Drug Type Synthetic peptide |
Synonyms |
Target |
Action antagonists, inhibitors |
Mechanism PDGFR antagonists(Platelet-derived growth factor receptor antagonists), PIGF inhibitors(phosphatidylinositol glycan anchor biosynthesis class F inhibitors), VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dystrophy, Macular | Discovery | China | - | |
Neoplasms | Discovery | China | - |